Advanced Instruments to acquire and merge with Nova Biomedical

Norwood, Mass. – Patricia Industries’ subsidiary Advanced Instruments, a manufacturer of analytical instruments for the biopharmaceutical and clinical markets, today announced the execution of a definitive agreement to acquire Nova Biomedical, a manufacturer of innovative analytical instruments and consumables that are vital in guiding the treatment of patients and the development of biotechnology therapeutics. Following the [...]

Zymo Research Responds to Recent Court Ruling in Litigation with QIAGEN GmbH

IRVINE, Calif. – Zymo Research Corporation acknowledges the recent ruling, on March 14, 2025, by the United States District Court for the Central District of California in the ongoing litigation with QIAGEN GmbH. The Court has denied QIAGEN’s Partial Motion to Dismiss and, in the alternative, to stay certain counterclaims brought by Zymo Research, including claims [...]

Alamar Biosciences Announces First Five Distribution Partners, Expanding Commercial Support in Asia Pacific

Fremont, CA – Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, is pleased to announce the signing of five new distribution partners to expand its global presence. The company has partnered with established industry leaders across key international markets to enhance access to its innovative proteomics technologies. The newly [...]

GenScript Unveils Prime Editing Boost with the Broad Institute Deal

PISCATAWAY, N.J. -- GenScript Biotech Corp., a global biotechnology leader in life science, biologics manufacturing, synthetic biology, and cell therapies, announced an exciting investment in gene editing technology. GenScript has signed a licensing agreement with the Broad Institute of MIT to access Broad's Prime Editing technology. "This partnership with the Broad Institute marks an exhilarating new chapter [...]

PHC and Cyfuse Develop Innovative Production Technology for the Commercialization of 3D Cell Products

Tokyo, Japan -- PHC Corporation (Headquarters: Chiyoda-ku, Tokyo; President: Nobuaki Nakamura; hereafter referred to as "PHC"), a subsidiary of PHC Holdings Corporation (Headquarters: Chiyoda-ku, Tokyo; President: Kyoko Deguchi), and Cyfuse Biomedical K.K. (Headquarters: Minato-ku, Tokyo; CEO: Shizuka Akieda; hereafter referred to as "Cyfuse") announce the development of a new production technology(*1) for the commercialization of the [...]

Agilent Research Catalyst Award Presented to Columbia University for Professor Pawel Muranski

Scientist recognized for pioneering advances in bioprocess development and biomanufacturing SANTA CLARA, Calif.--  Agilent Technologies Inc. (NYSE: A) today announced that Columbia University has received an Agilent Research Catalyst (ARC) Award on behalf of Dr. Pawel Muranski, an internationally recognized researcher and physician-scientist specializing in bone marrow transplant (BMT) and cancer cellular immunotherapy. Dr. Muranski is the Director of [...]

Teknova and Pluristyx Launch Proprietary PluriFreeze™ Cryopreservation System to Accelerate the Development of Cell Therapies

Innovative product line is purpose-built to streamline the manufacture of allogeneic cell therapies. Available exclusively from Teknova starting today. HOLLISTER, Calif. -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), and Pluristyx, Inc., today announced that Pluristyx’s PluriFreeze™ cryopreservation system is available for purchase exclusively from Teknova. Teknova is a leading producer of critical reagents for the [...]

Alliance for Genomic Discovery completes 250,000 whole genomes to accelerate drug discovery

Creates one of the largest, most comprehensive clinical genomic datasets of its kind; multiomic data to be added in next phase of program AGD members are using the population-level insights to uncover novel drug targets SAN DIEGO -- Illumina Inc. (NASDAQ: ILMN) and Nashville Biosciences, LLC (NashBio), a leading clinical and genomic data company and wholly [...]

Sapio Sciences Makes AI-Native Drug Discovery Seamless with NVIDIA BioNeMo

Integration of the NVIDIA BioNeMo platform enhances AI capabilities across the drug discovery lifecycle Baltimore, MD – Sapio Sciences, the science-aware™ lab informatics platform, today announced the integration of the NVIDIA BioNeMo platform into the Sapio Lab Informatics Platform. This integration brings AI-driven computational drug discovery directly into Sapio ELN (Electronic Lab Notebook), helping to streamline workflows and improve decision-making in [...]

Xcell Biosciences and Royal Perth Hospital to Develop Next Gen Automated TIL Manufacturing Workflow

Teams will collaborative to create an innovative TIL process on the AVATAR™ Foundry platform to enhance TILquality, quantity, and potency MELBOURNE, Australia & PERTH, Australia -- Xcell Biosciences Australia PTY LTD (Xcellbio), an affiliate of Xcell Biosciences, Inc., a platform company focused on cell and gene therapy applications, and Royal Perth Hospital announced a collaboration [...]

Access IBO on Knowledge Center